forty-four children with acute lymphoblastic leukemia ( all ) who had relapsed ( n = 43 ) or had refractory disease ( n = 1 ) were intensively treated with combination chemotherapy , had remission bone marrow ( bm ) harvested and purged in vitro with monoclonal antibodies specific for leukemia-associated antigens , underwent postharvest ablative chemotherapy and radiotherapy and subsequently were infused with their autologous marrow .
C0005953
bone marrow
C0023418
associated